|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 799.80 USD | +0.56% |
|
+6.92% | +37.21% |
| 12-02 | Health Care Flat on Mixed Obesity-Drug Fortunes - Health Care Roundup | DJ |
| 12-02 | Tesla leads November's global market value surge | RE |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
| Capitalization | 716B 682B 635B 566B 1,008B 60,688B 1,109B 7,885B 2,927B 24,868B 2,691B 2,630B 106,830B | P/E ratio 2024 * |
62.3x | P/E ratio 2025 * | 36.7x |
|---|---|---|---|---|---|
| Enterprise value | 737B 703B 654B 583B 1,037B 62,479B 1,142B 8,118B 3,013B 25,602B 2,770B 2,708B 109,983B | EV / Sales 2024 * |
16.1x | EV / Sales 2025 * | 12.5x |
| Free-Float |
99.81% | Yield 2024 * |
0.65% | Yield 2025 * | 0.75% |
More valuation ratios
* Estimated data
More news
Last Transcript: Eli Lilly and Company
More recommendations
More press releases
More news
| 1 day | -0.07% | ||
| 1 week | +6.92% | ||
| Current month | +0.56% | ||
| 1 month | -2.34% | ||
| 3 months | -16.69% | ||
| 6 months | -2.50% | ||
| Current year | +37.21% |
1 week
773.95
807.00
1 month
711.40847.27
Current year
579.05972.53
1 year
561.65972.53
3 years
231.87972.53
5 years
115.92972.53
10 years
64.18972.53
| Director | Title | Age | Since |
|---|---|---|---|
David Ricks
CEO | Chief Executive Officer | 56 | 31/12/2016 |
Ruth Gimeno
PSD | President | - | - |
Lucas Montarce
DFI | Director of Finance/CFO | 47 | 08/09/2024 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jon Fyrwald
BRD | Director/Board Member | 64 | 31/12/2004 |
Ralph Alvarez
BRD | Director/Board Member | 68 | 31/03/2009 |
| Director/Board Member | 52 | 11/12/2011 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 6.49% | 20 M€ | +15.66% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +0.56% | +6.92% | +36.94% | +221.04% | 716B | ||
| +2.44% | +3.32% | +11.03% | +117.89% | 474B | ||
| -0.14% | -0.24% | -2.26% | -2.07% | 373B | ||
| -0.63% | +2.72% | +26.75% | +56.82% | 323B | ||
| -1.01% | +1.44% | -2.75% | +35.16% | 257B | ||
| +0.27% | +0.75% | +6.93% | -29.96% | 233B | ||
| -0.14% | -0.58% | +9.09% | +25.46% | 211B | ||
| -0.55% | +0.76% | +3.49% | +26.94% | 209B | ||
| -1.69% | -5.58% | +2.07% | +38.50% | 152B | ||
| -1.49% | +0.66% | -10.69% | -52.78% | 149B | ||
| Average | +0.04% | +1.25% | +8.06% | +43.70% | 309.77B | |
| Weighted average by Cap. | +0.24% | +2.14% | +13.49% | +78.41% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 45.66B 43.51B 40.47B 36.11B 64.24B 3,869B 70.7B 503B 187B 1,585B 172B 168B 6,811B | 58.4B 55.65B 51.77B 46.19B 82.17B 4,949B 90.44B 643B 239B 2,028B 219B 215B 8,712B |
| Net income | 11.31B 10.77B 10.02B 8.94B 15.91B 958B 17.51B 124B 46.21B 393B 42.48B 41.53B 1,687B | 19.63B 18.71B 17.4B 15.53B 27.62B 1,664B 30.4B 216B 80.23B 682B 73.76B 72.11B 2,929B |
| Net Debt | 21.13B 20.14B 18.73B 16.71B 29.74B 1,791B 32.73B 233B 86.37B 734B 79.4B 77.63B 3,153B | 13.11B 12.49B 11.62B 10.37B 18.45B 1,111B 20.3B 144B 53.57B 455B 49.25B 48.15B 1,956B |
More financial data
* Estimated data
Employees
43,000
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/12/24 | 799.80 $ | +0.56% | 2,854,443 |
| 29/11/24 | 795.35 $ | +0.91% | 2,206,918 |
| 27/11/24 | 788.19 $ | -0.14% | 2,714,656 |
| 26/11/24 | 789.32 $ | +4.55% | 6,622,610 |
Delayed Quote Nyse, December 02, 2024 at 09:00 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
799.80USD
Average target price
992.82USD
Spread / Average Target
+24.13%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LLY Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition